Worth Venture Partners’s Insmed INSM Stock Holding History

Worth Venture Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-14,300	Closed	-$358	–	58
2024 Q2	$358	Sell	14,300 -1,100	-7%	-$42.7K	﹤0.01%	56
2024 Q1	$8.47K	Buy	+15,400	New	+$431K	0.06%	58
2019 Q1	–	Sell	-95,500	Closed	-$206K	–	103
2018 Q4	$206K	Buy	95,500 +19,100	+25%	+$305K	0.16%	63
2018 Q3	$178K	Sell	76,400 -17,600	-19%	-$397K	0.13%	74
2018 Q2	$217K	Buy	94,000 +82,300	+703%	+$2.12M	0.18%	65
2018 Q1	$26K	Buy	+11,700	New	+$308K	0.02%	93
2017 Q4	–	Sell	-46,500	Closed	-$3K	–	124
2017 Q3	$3K	Buy	46,500 +9,900	+27%	+$189K	﹤0.01%	124
2017 Q2	$232K	Sell	36,600 -5,000	-12%	-$85.4K	0.2%	78
2017 Q1	$263K	Buy	+41,600	New	+$642K	0.23%	87

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Worth Venture Partners's INSM Position: Q2 2024 in Review

Worth Venture Partners sold out of Insmed (INSM) in Q2 2024, closing a stake of 15,400 shares — an estimated $597K sold.

Worth Venture Partners first reported a position in INSM in Q1 2017 and held it in 4 quarters. The position peaked at $950K in Q3 2017. 378 funds tracked by Wall St. Rank hold INSM as of Q2 2024.

Worth Venture Partners reported no remaining Insmed position as of Q2 2024 after selling out during the quarter.
Worth Venture Partners sold 15,400 Insmed shares in Q2 2024, an estimated $597K.
Worth Venture Partners first reported a position in Insmed in Q1 2017 and held it in 4 quarters.
Worth Venture Partners's Insmed position peaked at $950K in Q3 2017.
378 funds tracked by Wall St. Rank held Insmed as of Q2 2024.

Based on Worth Venture Partners's 13F filing for Q2 2024, filed 14 Aug 2024.